We use cookies to enhance your browsing experience, analyze website traffic, and maintain essential site functionality. By clicking "Accept All", you consent to our use of cookies. For more details, please review our Privacy Policy.

Guardion Health Sciences Stock (NASDAQ:GHSI)


Chart

Previous Close

$3.22

52W Range

$3.04 - $18.00

50D Avg

$3.22

200D Avg

$6.02

Market Cap

$4.35M

Avg Vol (3M)

$35.35K

Beta

0.71

Div Yield

$3.25 (256.21%)

GHSI Company Profile


Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

9

IPO Date

Apr 05, 2019

Website

GHSI Performance


Total Return %
1D
5D
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
GHSI
S&P 500
0.00%
0.00%
0.00%
0.00%
-67.51%
0.00%
-60.34%
-69.91%
-96.17%
-99.71%
2.07%
-0.84%
-7.69%
-6.85%
0.14%
-3.73%
10.39%
32.06%
134.65%
169.83%

Latest Earnings Call Transcripts


Q2 20Aug 12, 20 | 5:00 PM

Peer Comparison


TickerCompany
ORGOOrganogenesis Holdings Inc.
ADMPAdamis Pharmaceuticals Corporation
ACRXTalphera, Inc.
AGRXAgile Therapeutics, Inc.
EVOKEvoke Pharma, Inc.
AQSTAquestive Therapeutics, Inc.
IMCCIM Cannabis Corp.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools